Geode Capital Management, LLC I Teos Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 640,350 shares of ITOS stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

640,350

Previous 620,258 3.24%

Holding current value

$4.98 Million

Previous $9.2 Million 28.98%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.09 - $17.97 $202,728 - $361,053	20,092 Added 3.24%	640,350 $6.54 Million
Q2 2024 Aug 09, 2024	BUY	$10.33 - $18.09 $379,503 - $664,590	36,738 Added 6.3%	620,258 $9.2 Million
Q1 2024 May 13, 2024	BUY	$9.89 - $13.64 $144,987 - $199,962	14,660 Added 2.58%	583,520 $7.96 Million
Q4 2023 Feb 13, 2024	BUY	$8.57 - $11.06 $315,144 - $406,709	36,773 Added 6.91%	568,860 $6.23 Million
Q3 2023 Nov 13, 2023	BUY	$10.95 - $14.6 $329,321 - $439,095	30,075 Added 5.99%	532,087 $5.83 Million
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $268,594 - $374,952	20,773 Added 4.32%	502,012 $6.65 Million
Q1 2023 May 15, 2023	BUY	$13.02 - $22.62 $126,697 - $220,115	9,731 Added 2.06%	481,239 $6.55 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $437,621 - $531,943	24,627 Added 5.51%	471,508 $9.21 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $907,791 - $1.33 Million	48,806 Added 12.26%	446,881 $8.51 Million
Q2 2022 Aug 12, 2022	SELL	$16.57 - $35.1 $22,783 - $48,262	-1,375 Reduced 0.34%	398,075 $8.2 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $819,131 - $1.22 Million	25,662 Added 6.87%	399,450 $12.9 Million
Q4 2021 Feb 11, 2022	BUY	$26.23 - $47.86 $693,127 - $1.26 Million	26,425 Added 7.61%	373,788 $17.4 Million
Q3 2021 Nov 12, 2021	BUY	$23.91 - $29.58 $1.52 Million - $1.87 Million	63,385 Added 22.32%	347,363 $9.38 Million
Q2 2021 Aug 13, 2021	BUY	$17.9 - $36.1 $153,385 - $309,340	8,569 Added 3.11%	283,978 $7.28 Million
Q1 2021 May 12, 2021	BUY	$30.86 - $44.2 $2.91 Million - $4.17 Million	94,297 Added 52.07%	275,409 $9.41 Million
Q4 2020 Feb 12, 2021	BUY	$21.59 - $33.95 $665,317 - $1.05 Million	30,816 Added 20.5%	181,112 $6.13 Million
Q3 2020 Nov 13, 2020	BUY	$17.57 - $32.92 $2.64 Million - $4.95 Million	150,296 New	150,296 $3.71 Million

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $276M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC I Teos Therapeutics, Inc. Transaction History